FACTOR XIII (FIBRIN STABILISING FACTOR) IN HENOCH‐SCHÖNLEIN'S PURPURA

Acta Pædiatrica

Volumn 66, Issue 3, 1977, Pages 273-277

  HENRIKSSON, PER ^a   HEDNER, ULLA ^a   NILSSON, INGA MARIE ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

abnormal proteolysis; factor XIII; Henoch Sch nlein's purpura

Indexed keywords

BLOOD CLOTTING FACTOR 13;

ANAPHYLACTOID PURPURA; CHILD; DIAGNOSIS; MAJOR CLINICAL STUDY; THERAPY;

ADOLESCENT; CASE REPORT; CHILD; CHILD, PRESCHOOL; FACTOR XIII; FEMALE; FIBRINOGEN; FIBRINOLYSIS; GASTROINTESTINAL HEMORRHAGE; HUMAN; MALE; PLASMINOGEN; PURPURA, SCHOENLEIN-HENOCH;

EID: 0017365143     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1977.tb07893.x     Document Type: Article

References (24)

1. A new method for enumeration of platelets
2. Inhibitors of fibrin cross linking. Relevance for thrombolysis
3. Documentation of the plasma factor XIII deficiency in man
4. Plasma digestion of stabilized and nonstabilized fibrin illustrated by pH‐stat titration and thrombelastography
5. 2‐macroglobulin as trypsinprotein esterase
6. Immunochemical determination of human plasminogen
7. Ethanol gelation and fibrin monomers in plasma
8. Antithrombin III in a clinical material
9. Factor XIII in a clinical material
10. Fibrin‐stabilizing factor (factor XIII) in the foetus and the newborn infant
11. Generalized proteolysis in a young woman with Weber‐Christian disease (nodular nonsuppurative panniculitis)
12. Immunologic studies in haemophilia A
13. Transfusion therapy in congenital deficiencies of plasma factor XIII
14. Accelerated lysis of blood clots
15. Diagnostic and genetic studies on fibrin‐stabilizing factor with a new assay based on amine incorporation
16. Separation and estimation of “split products” of fibrinogen and fibrin in human serum
17. On an inherited autosomal haemorrhagic diathesis with antihaemophilic globulin (AHG) deficiency and prolonged bleeding time
18. Determination of fibrinogen and fibrinogenolytic activity
19. Erosive hemorrhagic gastroduodenitis with fibrinolysis and low factor XIII
20. A method for determining serum inhibitors of plasminogen activation
21. Effect of lysosomal cationic proteins from polymorphonuclear leukocytes upon the fibrinogen and fibrinolysis system
22. Effect of elastase‐like and chymotrypsin‐like neutral proteases from human granulocytes on isolated clotting factors